}

Tender For Tender For Supply Of Quadrivalent And Trivalent Seasonal Influenza Vaccine(Siv), delhi-Delhi

Statutory Bodies & Commissions/Committees has published Tender For Tender For Supply Of Quadrivalent And Trivalent Seasonal Influenza Vaccine(Siv). Submission Date for this Tender is 29-02-2024. Vaccines Tenders in delhi Delhi. Bidders can get complete Tender details and download the document.




Tender Notice

41934891
Corrigendum : Tender For Tender For Supply Of Quadrivalent And Trivalent Seasonal Influenza Vaccine(Siv)
Open Tender
Indian
Delhi
Delhi
29-02-2024

Tender Details

Tender For Supply Of Quadrivalent And Trivalent Seasonal Influenza Vaccine(Siv) Supply Of Quadrivalent And Trivalent Seasonal Influenza Vaccine Siv For Haj Session 2024 , Seasonal Influenza Vaccine (Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2024Influenza Season (Sh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • A B/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2024 Influenza Season (Sh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • A B/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2024 Influenza Season (Sh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • A B/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trrivalent Vaccines For Use In The 2024 Influenza Season (Sh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2024 Influenza Season (Sh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2024 Influenza Season (Sh) Contain The Following: Egg-Based Vaccines • An A/Victoria/4897/2022 (H1n1)Pdm09-Like Virus; • An A/Thailand/8/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2024 Influenza Season (Sh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • A B/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2024 Influenza Season (Sh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • A B/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Quadrivalent) (For Adults) Specification: As Per The Who Recommendations The Quadrivalent Vaccines For Use In The 2024 Influenza Season (Sh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And • A B/Phuket/3073/2013 (B/Yamagata Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2024 Influenza Season (Sh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trrivalent Vaccines For Use In The 2024 Influenza Season (Sh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trrivalent Vaccines For Use In The 2024 Influenza Season (Sh) Contain The Following: Cell- Or Recombinant-Based Vaccines • An A/Wisconsin/67/2022 (H1n1)Pdm09-Like Virus; • An A/Massachusetts/18/2022 (H3n2)-Like Virus; • A B/Austria/1359417/2021 (B/Victoria Lineage)-Like Virus; And Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months

Corrigendum Details

Sr No CorrigendumDate Corrignedum CorrigendumType NewSubmissionDate
1 06-02-2024 Corrigendum-1 Technical Bid 29-02-2024

Key Value

Document Fees
Refer document
EMD
INR 486500.0 /-
Tender Value
Refer document
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2024 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail